Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic …

Articles citing Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic …

Title / Author	Year
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent N Mottet, J Bellmunt, M Bolla, E Briers, MG Cumberbatch, M De Santis, ... European urology 71 (4), 618-629	2017
MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777	2018
Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use JO Barentsz, JC Weinreb, S Verma, HC Thoeny, CM Tempany, F Shtern, ... European urology 69 (1), 41	2016
Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis M de Rooij, EHJ Hamoen, JA Witjes, JO Barentsz, MM Rovers European urology 70 (2), 233-245	2016
Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? O Wegelin, HHE van Melick, L Hooft, JLHR Bosch, HB Reitsma, ... European urology 71 (4), 517-531	2017
NCCN guidelines insights: prostate cancer early detection, version 2.2016 PR Carroll, JK Parsons, G Andriole, RR Bahnson, EP Castle, ... Journal of the National Comprehensive Cancer Network 14 (5), 509-519	2016
What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel PC Moldovan, T Van den Broeck, R Sylvester, L Marconi, J Bellmunt, ... European urology 72 (2), 250-266	2017
A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment LP Bokhorst, R Valdagni, A Rannikko, Y Kakehi, T Pickles, CH Bangma, ... European urology 70 (6), 954-960	2016
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study O Rouvière, P Puech, R Renard-Penna, M Claudon, C Roy, ... The Lancet Oncology 20 (1), 100-109	2019
Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial PP Tonttila, J Lantto, E Pääkkö, U Piippo, S Kauppila, E Lammentausta, ... European urology 69 (3), 419-425	2016
Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naive patients with suspected prostate cancer F Porpiglia, M Manfredi, F Mele, M Cossu, E Bollito, A Veltri, S Cirillo, ... European urology 72 (2), 282-288	2017
Assessment of PI-RADS v2 for the detection of prostate cancer M Kasel-Seibert, T Lehmann, R Aschenbach, FV Guettler, M Abubrig, ... European journal of radiology 85 (4), 726-731	2016
Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers SY Park, DC Jung, YT Oh, NH Cho, YD Choi, KH Rha, SJ Hong, K Han Radiology 280 (1), 108-116	2016
Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the Prostate MR Imaging Study (PROMIS) R Faria, MO Soares, E Spackman, HU Ahmed, LC Brown, R Kaplan, ... European urology 73 (1), 23-30	2018
Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12‐core biopsy results JS Wysock, N Mendhiratta, F Zattoni, X Meng, M Bjurlin, WC Huang, ... Bju International 118 (4), 515-520	2016
Prostate imaging-reporting and data system steering committee: PI-RADS v2 status update and future directions AR Padhani, J Weinreb, AB Rosenkrantz, G Villeirs, B Turkbey, J Barentsz European urology 75 (3), 385-396	2019
Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous negative biopsy NL Hansen, C Kesch, T Barrett, B Koo, JP Radtke, D Bonekamp, ... BJU international 120 (5), 631-638	2017
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer FJH Drost, DF Osses, D Nieboer, EW Steyerberg, CH Bangma, ... Cochrane Database of Systematic Reviews	2019
The role of multiparametric magnetic resonance imaging/ultrasound fusion biopsy in active surveillance TM Ma, JJ Tosoian, EM Schaeffer, P Landis, S Wolf, KJ Macura, JI Epstein, ... European urology 71 (2), 174-180	2017
Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-naïve men? MG Schouten, M van der Leest, M Pokorny, M Hoogenboom, JO Barentsz, ... European urology 71 (6), 896-903	2017

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.